Skin Disorders Video 3: Boils

News
Article

A boil, painful and nasty: Is it a cyst? Is it a bug bite? Should you culture? Is it MRSA? How should you treat it? What if it recurs? Listen and learn.

Ted Rosen, MD, Professor of Dermatology at Baylor College of Medicine, offers bite-size pieces of useful clinical information on the “Top 10” skin disorders you see in your daily practice.

Segment 3: Boils

For more webinar videos, click here.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Sydney Jennings
April 18th 2025
Article

Dupilumab (Dupixent) is the first new targeted therapy for CSU in over a decade.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years

ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years

Sydney Jennings
April 17th 2025
Article

The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Study Shows High Rate of Eczema Type Overlap: Daily Dose / image credit: ©New Africa/AdobeStock

Study Shows High Rate of Eczema Type Overlap: Daily Dose

Sydney Jennings
April 11th 2025
Article

Your daily dose of the clinical news you may have missed.

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

Sydney Jennings
April 9th 2025
Article

AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.

© 2025 MJH Life Sciences

All rights reserved.